Log In
Print this Print this

CaCP29, IFX-1

  Manage Alerts
Collapse Summary General Information
Company InflaRx GmbH
DescriptionMAb against complement 5a (C5a)
Molecular Target Complement 5a (C5a)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today